2019 – Page 4 – Clinical Trial Results

Dr. John McMurray and Dr. C. Michael Gibson Discuss: DAPA-HF: The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF): Results in Nondiabetic Patients

November 16, 2019

Disclosures: TBA

Dr. Jean Claude-Tardif and Dr. Adam T Phillips Discuss: COLCOT: The COLchicine Cardiovascular Outcomes Trial

November 16, 2019

Disclosures: TBA

Dr. Ole De Backer and Dr. C. Michael Gibson Discuss: GALILEO-4D: Randomized Clinical Trial Comparing a Rivaroxaban-Based Strategy With an Antiplatelet-Based Strategy for the Prevention of Subclinical Leaflet Thrombosis in Transcatheter Aortic Valves

November 16, 2019

Disclosures: TBA

Dr. Frederick Raal and Dr. C. Michael Gibson Discuss: Phase 3 ORION-9: Safety and Efficacy of Inclisiran in Patients With Heterozygous Familial Hypercholesterolemia – Results From the Phase 3 ORION-9 Trial

November 16, 2019

Disclosures: TBA

Dr. Chadi Alraies Presents: AHA 2019 Wrap-Up in Arabic

November 16, 2019

Disclosures: TBA

Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: The Role of the \Interventional Lipidologist\” – Sponsored by an independent educational grant from The Medicines Company”

November 16, 2019

Disclosures: TBA

Advancing Cell Therapies for Coronary Microvascular Dysfunction: Experts Roundtable – Discussion

November 16, 2019

Disclosures: TBA

Dr. Usman Baber and Dr. C. Michael Gibson Discuss: TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

September 29, 2019

Disclosures: TBA

Dr. Giora Weisz Presents: TCT 2019 Wrap-Up in Hebrew

September 29, 2019

Disclosures: TBA

Dr. Sigmund Silber Presents: TCT 2019 Wrap-Up in German

September 29, 2019

Disclosures: TBA